Cypress Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.8M | Buy |
79,197
+3,643
| +5% | +$212K | 0.54% | 50 |
|
|
2025
Q4 | $4.08M | Buy |
75,554
+2,193
| +3% | +$105K | 0.46% | 51 |
|
|
2025
Q3 | $3.31M | Sell |
73,361
-478
| -0.6% | -$22.3K | 0.4% | 62 |
|
|
2025
Q2 | $3.42M | Buy |
73,839
+1,570
| +2% | +$77.1K | 0.43% | 56 |
|
|
2025
Q1 | $4.41M | Buy |
72,269
+2,743
| +4% | +$160K | 0.58% | 48 |
|
|
2024
Q4 | $3.93M | Sell |
69,526
-5,350
| -7% | -$299K | 0.48% | 53 |
|
|
2024
Q3 | $3.87M | Sell |
74,876
-24,205
| -24% | -$1.14M | 0.44% | 57 |
|
|
2024
Q2 | $4.11M | Sell |
99,081
-1,912
| -2% | -$85.6K | 0.49% | 53 |
|
|
2024
Q1 | $5.48M | Buy |
100,993
+1,745
| +2% | +$88.9K | 0.66% | 41 |
|
|
2023
Q4 | $5.09M | Buy |
99,248
+1,126
| +1% | +$59.1K | 0.66% | 42 |
|
|
2023
Q3 | $5.69M | Sell |
98,122
-1,374
| -1% | -$84.2K | 0.82% | 30 |
|
|
2023
Q2 | $6.36M | Sell |
99,496
-9,805
| -9% | -$657K | 0.92% | 28 |
|
|
2023
Q1 | $7.58M | Sell |
109,301
-8,367
| -7% | -$590K | 1.16% | 18 |
|
|
2022
Q4 | $8.47M | Buy |
117,668
+2,756
| +2% | +$208K | 1.28% | 16 |
|
|
2022
Q3 | $8.17M | Buy |
114,912
+6,747
| +6% | +$489K | 1.36% | 12 |
|
|
2022
Q2 | $8.33M | Sell |
108,165
-934
| -0.9% | -$71.1K | 1.27% | 16 |
|
|
2022
Q1 | $7.97M | Buy |
109,099
+9,759
| +10% | +$655K | 0.98% | 26 |
|
|
2021
Q4 | $6.19M | Buy |
99,340
+7,604
| +8% | +$446K | 0.78% | 37 |
|
|
2021
Q3 | $5.43M | Sell |
91,736
-1,344
| -1% | -$88.5K | 0.74% | 37 |
|
|
2021
Q2 | $6.22M | Sell |
93,080
-5,353
| -5% | -$349K | 0.84% | 31 |
|
|
2021
Q1 | $6.21M | Sell |
98,433
-13,289
| -12% | -$827K | 0.88% | 31 |
|
|
2020
Q4 | $6.93M | Sell |
111,722
-5,307
| -5% | -$326K | 1.04% | 30 |
|
|
2020
Q3 | $7.05M | Buy |
117,029
+3,956
| +3% | +$238K | 1.18% | 23 |
|
|
2020
Q2 | $6.65M | Buy |
113,073
+6,065
| +6% | +$363K | 1.22% | 22 |
|
|
2020
Q1 | $5.96M | Sell |
107,008
-397
| -0.4% | -$24.3K | 1.38% | 20 |
|
|
2019
Q4 | $6.89M | Buy |
107,405
+35,304
| +49% | +$2.02M | 1.23% | 20 |
|
|
2019
Q3 | $3.66M | Buy |
72,101
+11,764
| +19% | +$553K | 0.7% | 45 |
|
|
2019
Q2 | $2.74M | Buy |
60,337
+3,269
| +6% | +$152K | 0.54% | 60 |
|
|
2019
Q1 | $2.72M | Sell |
57,068
-2,552
| -4% | -$127K | 0.56% | 57 |
|
|
2018
Q4 | $3.1M | Buy |
59,620
+1,944
| +3% | +$104K | 0.71% | 45 |
|
|
2018
Q3 | $3.58M | Sell |
57,676
-1,396
| -2% | -$82.8K | 0.68% | 52 |
|
|
2018
Q2 | $3.27M | Sell |
59,072
-21,484
| -27% | -$1.16M | 0.67% | 50 |
|
|
2018
Q1 | $5.09M | Buy |
80,556
+6,410
| +9% | +$412K | 1.07% | 26 |
|
|
2017
Q4 | $4.54M | Buy |
74,146
+4,125
| +6% | +$258K | 0.95% | 30 |
|
|
2017
Q3 | $4.46M | Sell |
70,021
-325
| -0.5% | -$19K | 0.95% | 29 |
|
|
2017
Q2 | $3.92M | Sell |
70,346
-6,995
| -9% | -$381K | 0.87% | 36 |
|
|
2017
Q1 | $4.21M | Sell |
77,341
-4,906
| -6% | -$269K | 0.98% | 34 |
|
|
2016
Q4 | $4.81M | Sell |
82,247
-9,693
| -11% | -$530K | 1.14% | 27 |
|
|
2016
Q3 | $4.96M | Sell |
91,940
-690
| -0.7% | -$44.3K | 1.18% | 27 |
|
|
2016
Q2 | $6.81M | Sell |
92,630
-1,812
| -2% | -$128K | 1.59% | 18 |
|
|
2016
Q1 | $6.03M | Buy |
94,442
+87
| +0.1% | +$5.49K | 1.48% | 24 |
|
|
2015
Q4 | $6.49M | Sell |
94,355
-16,190
| -15% | -$1.07M | 1.57% | 19 |
|
|
2015
Q3 | $6.54M | Buy |
110,545
+2,045
| +2% | +$130K | 1.61% | 19 |
|
|
2015
Q2 | $7.22M | Buy |
108,500
+525
| +0.5% | +$34.6K | 1.66% | 15 |
|
|
2015
Q1 | $6.96M | Buy |
107,975
+1,062
| +1% | +$66.5K | 1.59% | 15 |
|
|
2014
Q4 | $6.31M | Sell |
106,913
-9,436
| -8% | -$532K | 1.46% | 19 |
|
|
2014
Q3 | $5.95M | Sell |
116,349
-4,050
| -3% | -$202K | 1.41% | 20 |
|
|
2014
Q2 | $5.84M | Sell |
120,399
-942
| -0.8% | -$46.4K | 1.37% | 21 |
|
|
2014
Q1 | $6.3M | Sell |
121,341
-9,837
| -7% | -$523K | 1.55% | 17 |
|
|
2013
Q4 | $6.97M | Sell |
131,178
-4,990
| -4% | -$254K | 1.71% | 14 |
|
|
2013
Q3 | $6.3M | Sell |
136,168
-1,989
| -1% | -$87.3K | 1.56% | 15 |
|
|
2013
Q2 | $6.17M | Buy |
+138,157
| New | +$6M | 1.29% | 20 |
|
Other funds holding BMY
VCM
VPM
Cypress Capital Group's BMY Position: Q1 2026 in Review
Cypress Capital Group increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q1 2026, buying an estimated $212K and bringing the position to 79,197 shares worth $4.8M. The position accounts for 0.54% of the portfolio, ranked #50.
Cypress Capital Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.47M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Cypress Capital Group held 79,197 shares of Bristol-Myers Squibb worth $4.8M as of Q1 2026.
- Cypress Capital Group bought 3,643 Bristol-Myers Squibb shares in Q1 2026, an estimated $212K.
- Bristol-Myers Squibb made up 0.54% of Cypress Capital Group's portfolio in Q1 2026, its #50 holding.
- Cypress Capital Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Cypress Capital Group's Bristol-Myers Squibb position peaked at $8.47M in Q4 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.